查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球蛋白質測定市場——行業規模、份額、趨勢、競爭、機會、預測、按類型、按產品、按技術、按應用、按最終用戶、按地區、按競爭對手分析 (2018-2028)
市場調查報告書
商品編碼
1244134

全球蛋白質測定市場——行業規模、份額、趨勢、競爭、機會、預測、按類型、按產品、按技術、按應用、按最終用戶、按地區、按競爭對手分析 (2018-2028)

Protein Assays Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028 Segmented By Type, By Product, By Technology, By Application, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 114 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球蛋白質分析市場將在 2024 年至 2028 年的預測期內經歷強勁增長。

這一市場增長的主要驅動力是在蛋白質組學領域開展的嚴格研究和開發。 例如，2022 年 6 月，班加羅爾印度科學研究所 (IISc) 的一些科學家開發了一種全新的合成□，稱為微型蛋白質。 據幾位研究人員稱，這些微型蛋白可以中和 SARS-CoV-2 樣病毒。 更重要的是，根據《自然化學生物學》雜誌的報導，這些微型蛋白已被證明能夠阻止病毒進入宿主細胞。 它還可以捆綁病毒顆粒以降低它們引起感染的能力。 此類研究進展可能對全球蛋白質分析市場的增長產生積極影響。

用於癌症診斷的蛋白質檢測

蛋白質分析為疾病診斷、分類和監測提供了機會。 必須滿足某些要求才能使測定在治療上有用。 首先，您需要能夠檢測您感興趣的蛋白質。 檢測必須對待□□檢測的蛋白質敏感且特異。 此外，為了使這些測試有效，它們必須使用現成的患者樣本。 此外，實驗室工作人員必須接受適當的培訓才能執行這些過程，並且在臨床環境中必須隨時可以使用化驗設備。 此外，化驗必須在勞動力和成本方面高效，並且足夠穩健以生成跨實驗室和員工的可比較數據。

許多基於流式細胞術、□聯免疫吸附測定 (ELISA) 和免疫組織化學 (IHC) 的蛋白質測定用於癌症檢測、預後和治療。 這些方法可以檢測 100 多種獨特的蛋白質，但並非所有蛋白質都與癌症有關。 免疫組織化學是檢測乳腺癌患者 Her2 標誌物和雌激素受體最合適的方法。 ELISA 是另一種識別血液中癌症生物標誌物的重要方法。 該方法可以同時檢測多種標記物，具有很高的特異性和靈敏度。 例如，針對卵巢癌開發的 6 標記 ELISA 報告的特異性為 99.4%，靈敏度為 95.3%。

因此，全球範圍內越來越多的癌症病例及其檢測可能會顯著擴大全球蛋白質檢測市場。

蛋白質組學研究的政府資助

許多政府提供資金支持蛋白質組學領域的新研究和開發。 例如，印度政府的印度醫學研究委員會 (ICMR) 向生物信息學研究所 (IOB) 和 ICMR-Regional Medical Research Centre, NE region, Dibrugarh 發表了一份聲明，題為“Proteomics and biochemical analysis for identification用於預測的新型生物標誌物的研究 我們資助了“妊娠高血壓綜合徵 (PIH)：來自 Dibrugarh 的健康和人口統計學隊列”項目。IOB 對具有特徵的晚期妊娠婦女的尿液樣本進行了蛋白質分析。該項目的主要目標是開發及時檢測妊娠高血壓綜合徵的蛋白標誌物。

此外，臨床蛋白質組學腫瘤分析聯盟 (CPTAC) 啟發了美國國家癌症研究所 (NCI) 的小企業創新研究 (SBIR) 發展中心於 2020 年 8 月宣布的資助。 該演示文稿呼籲開發高通量單細胞蛋白質組發現技術。 這個機會旨在促進我們對癌症如何開始和擴散的理解，以及促進在微尺度上發現和臨床使用強大的癌症生物標誌物。

此外，Genome Canada 和 Genome BC 在 2018 年為蛋白質研究提供了超過 180,000 美元的資金。 這筆資金導致了針對各種疾病的新型診斷和治療方法的開發。

這些發現可以為全球蛋白質分析市場提供有利可圖的機會。

近期發展

  • PerkinElmer 是一家醫療生命科學公司，於 2022 年 4 月推出了兩款檢測試劑盒，分別名為均相時間分辨熒光 (HTRF) 和 AlphaLISA。 這些試劑盒用於及時檢測和定量中國倉鼠卵巢 (CHO) 宿主細胞蛋白 (HCP) 雜質。
  • 領先的蛋白質組學公司 Biognosys 於 2022 年 3 月推出了其蛋白質組學平台，為製藥和診斷公司提供用於研發的生物學理解。
  • Eli Lilly and Company 於 2021 年 7 月收購了 Protomar Technologies。
  • GeoMx DSP Protein Assays 由生物技術公司 NanoString Technologies, Inc. 於 2020 年 11 月推出。

市場細分

全球蛋白質分析市場根據類型、產品、技術、應用、最終用戶和地區進行細分。 按類型，它們分為染料結合測定、基於試紙的測定、基於銅離子的測定等。 按產品分類，分為試劑、試劑盒和儀器/附件。 按照技術，它們分為量熱蛋白測定、熒光蛋白測定和吸光度蛋白測定。 按應用分為藥物發現與開發、疾病診斷等。 基於最終用戶，市場進一步細分為製藥和生物技術公司、臨床實驗室、醫院、學術研究機構等。

公司簡介

全球蛋白質分析市場的主要參與者包括 Becton Dickinson and Co、Thermo Fisher Scientific Inc、Bio-Rad Laboratories Inc、Merck KGaA、Abcam PLC、PerkinElmer Inc、QIAGEN NV、Lonza Group AG、Bio-Techne Corp、Illumina公司等。

報告範圍：

本報告將全球蛋白質分析市場分為以下幾類，行業趨勢詳述如下：

蛋白質測定市場，按類型

  • 染料結合分析
  • 基於試紙的檢測
  • 使用銅離子進行檢測
  • 其他

蛋白質測定市場，按產品分類：

  • 試劑
  • 工具包
  • 設備和配件

蛋白質檢測市場，按技術分類：

  • 蛋白質比色法
  • 使用熒光的蛋白質測定方法
  • 基於吸光度的蛋白質測定

蛋白質檢測市場，按應用：

  • 藥物發現和開發
  • 疾病診斷
  • 其他

最終用戶的蛋白質測定市場：

  • 製藥公司、生物技術公司
  • 臨床實驗室
  • 醫院
  • 學術研究機構
  • 其他

按地區劃分的蛋白質測定市場：

  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞
  • 歐洲
    • 法國
    • 德國
    • 英國
    • 意大利
    • 西班牙
  • 北美
    • 美國
    • 墨西哥
    • 加拿大
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
  • 中東和非洲
    • 南非
    • 沙特阿拉伯
    • 阿聯酋

競爭格局

公司概況：對全球蛋白質分析市場主要參與者的深入分析。

可自定義：

根據市場數據，TechSci Research 根據公司的具體需求提供定制服務。 該報告可以定制為：

公司信息

  • 對其他市場參與者（最多 5 家公司）進行深入分析和概況分析

內容

第 1 章概述

  • 市場定義
  • 市場範圍
    • 目標市場
    • 研究目標年份
    • 主要市場細分

第二章研究方法論

  • 調查目的
  • 基線調查方法
  • 主要行業合作夥伴
  • 主要協會和次要信息
  • 調查方法
  • 數據三角測量和驗證
  • 假設和限制

第 3 章執行摘要

  • 市場概覽
  • 主要市場細分概述
  • 主要市場參與者概覽
  • 主要地區/國家概覽
  • 市場驅動因素、挑戰和趨勢概述

第 4 章 VOC（客戶之聲）

第5章臨床試驗分析

  • 正在進行的臨床試驗
  • 已完成臨床試驗
  • 已完成臨床試驗
  • 管道細分（按開發階段）
  • 管道細分（按狀態
  • 管道分解（按測試應用）
  • 按地區劃分的渠道細分
  • 臨床試驗熱圖

第六章專利分析

第 7 章蛋白質檢測的全球市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按類型（染料結合測定、基於試紙的測定、基於銅離子的測定等）
    • 按產品（試劑、試劑盒、儀器、配件）
    • 按技術（比色蛋白質測定、熒光蛋白質測定、吸光度蛋白質測定）
    • 按應用（藥物發現/開發、疾病診斷等）
    • 最終用戶（製藥公司、生物技術公司、臨床實驗室、醫院、學術研究機構等）
    • 按地區
    • 按公司分類（2022 年）
  • 產品市場地圖
    • 按類型
    • 按產品分類
    • 按技術
    • 通過申請
    • 最終用戶
    • 按地區

第 8 章亞太地區蛋白質檢測市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按類型（染料結合測定、基於試紙的測定、基於銅離子的測定等）
    • 按產品（試劑、試劑盒、儀器、配件）
    • 通過技術（比色法、熒光法、吸收法）
    • 按應用（藥物發現/開發、疾病診斷等）
    • 最終用戶（製藥公司、生物技術公司、臨床實驗室、醫院、學術研究機構等）
    • 按國家
  • 亞太地區：國家/地區分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞

第 9 章歐洲蛋白質分析市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按類型（染料結合測定、基於試紙的測定、基於銅離子的測定等）
    • 按產品（試劑、試劑盒、儀器、配件）
    • 通過技術（比色法、熒光法、吸收法）
    • 按應用（藥物發現/開發、疾病診斷等）
    • 最終用戶（製藥公司、生物技術公司、臨床實驗室、醫院、學術研究機構等）
    • 按國家
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 意大利
    • 西班牙

第 10 章北美蛋白質分析市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按類型（染料結合測定、基於試紙的測定、基於銅離子的測定等）
    • 按產品（試劑、試劑盒、儀器、配件）
    • 通過技術（比色法、熒光法、吸收法）
    • 按應用（藥物發現/開發、疾病診斷等）
    • 最終用戶（製藥公司、生物技術公司、臨床實驗室、醫院、學術研究機構等）
    • 按國家
  • 北美：國家/地區分析
    • 美國
    • 墨西哥
    • 加拿大

第11章南美蛋白質分析市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按類型（染料結合測定、基於試紙的測定、基於銅離子的測定等）
    • 按產品（試劑、試劑盒、儀器、配件）
    • 通過技術（比色法、熒光法、吸收法）
    • 按應用（藥物發現/開發、疾病診斷等）
    • 最終用戶（製藥公司、生物技術公司、臨床實驗室、醫院、學術研究機構等）
    • 按國家
  • 南美洲：：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 12 章中東和非洲蛋白質測定市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按類型（染料結合測定、基於試紙的測定、基於銅離子的測定等）
    • 按產品（試劑、試劑盒、儀器、配件）
    • 按技術（比色蛋白質測定、熒光蛋白質測定、吸光度蛋白質測定）
    • 按應用（藥物發現/開發、疾病診斷等）
    • 最終用戶（製藥公司、生物技術公司、臨床實驗室、醫院、學術研究機構等）
    • 按國家
  • MEA：國家分析
    • 南非蛋白質測定
    • 沙特阿拉伯蛋白質檢測
    • 阿聯酋蛋白質分析

第 13 章市場動態

  • 司機
    • 蛋白質組學研究進展
    • 增加政府資助
    • 通過蛋白質分析檢測癌症
  • 做
    • 嚴格的監管框架
    • 缺乏熟練的專業人員
    • 蛋白質分析開發中的挑戰

第十四章市場趨勢與發展

  • 化驗裝置的小型化
  • 生物標誌物的進展
  • 新產品發布次數增加

第15章競爭格局

  • Business Overview
  • Company Snapshot
  • Products & Services
  • Financials（As Reported）
  • Recent Developments
  • SWOT Analysis
    • Becton Dickinson and Co
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories Inc
    • Merck KGaA
    • Abcam PLC
    • PerkinElmer Inc.
    • QIAGEN NV
    • Lonza Group AG
    • Bio-Techne Corp
    • Illumina Inc

第16章 戰略建議

簡介目錄
Product Code: 7415

Global protein assays market will undergo vigorous growth in the forecast period, 2024-2028. The principal factor behind this market growth is the rigorous research and development taking place in proteomics. For example, a brand-new category of synthetic peptides, better known as mini proteins, was developed by some scientists working at the Indian Institute of Science (IISc), Bangalore in June 2022. According to a few researchers, these mini proteins have the potential to neutralize SARS-CoV-2-like viruses. Moreover, based on work from the journal Nature Chemical Biology, it has come into the picture that these mini proteins can inhibit the virus from entering the host cell. Also, they can clutch the virus particles together to deteriorate their ability to cause infection. This progress in research can positively impact the growth of the global protein assay market.

During the forecast period, the market expansion is going to be supported by increased expenditures made by leading players in the development of cutting-edge & efficient medications & diagnostic instruments. For instance, Bruker Corp. introduced the two new timsTOF instruments in June 2021. It makes new techniques and uses possible, such as the unbiased, deep multi-omic biomarker discovery process and epi proteomics/PTM characterization. Additionally, they further develop & facilitate these cutting-edge applications & techniques in cancer liquid biopsy research.

Protein Assays for Cancer Diagnosis

Opportunities for disease diagnosis, classification, and monitoring are provided by protein analysis. An assay must fulfill specific requirements to be therapeutically relevant. To begin with, it must be capable of detecting the desired protein or proteins. An assay also needs to be specific to the protein it is meant to detect in addition to being sensitive. These tests must also work with readily accessible patient samples to be effective. Additionally, laboratory staff must be properly trained to carry out these processes, and the assay's equipment must be easily obtainable in clinical settings. Moreover, assays must be efficient in terms of labor and cost, as well as robust enough to produce data that can be compared across laboratories and staff.

Numerous protein assays based on flow cytometry, enzyme-linked immunosorbent assay (ELISA), and immunohistochemistry (IHC) are employed for the detection, prognosis, and treatment of cancer. These methods can detect over 100 distinctive proteins (not all cancer related). Immunohistochemistry has found its best application in detecting Her2 marker and estrogen receptors in patients with breast cancer. ELISA is another remarkable method to identify cancer biomarkers in blood. This method can detect several markers at the same time with high specificity and sensitivity. For instance, 99.4% specificity and 95.3% sensitivity were reported from a six-marker ELISA developed for ovarian cancer.

Therefore, the increasing number of cancer cases across the globe and their detection can escalate the global protein assay market considerably.

Government Funding for Research in Proteomics

Governments of quite a few countries are offering funding to assist new research and development in the field of proteomics. For example, the Indian Council of Medical Research (ICMR), Government of India provided funding to the Institute of Bioinformatics (IOB) as well as ICMR-Regional Medical Research Centre, NE region, Dibrugarh for a project named "Proteomics and biochemical analysis for identification of novel biomarkers for predicting pregnancy-induced hypertension (PIH): In a health and demographic cohort from Dibrugarh." The IOB will be conducting protein analysis of urine samples of pregnant women in distinctive trimesters. The chief aim of this project is to develop a protein marker for the timely detection of PIH.

Furthermore, the Clinical Proteomic Tumor Analysis Consortium (CPTAC) served as an inspiration for funding that was announced by the National Cancer Institute's (NCI) Small Business Innovation Research (SBIR) Development Center in August 2020. The announcement calls for the development of high-throughput single-cell proteome discovery technologies. This opportunity aims to improve our understanding of how cancer begins and spreads while also facilitating the discovery of powerful cancer biomarkers and their clinical utilization on a micro-scale.

In addition, Genome Canada and Genome BC offered a funding amount of over 18 million for protein research in the year 2018. This funding resulted in the development of novel diagnostic and treatment approaches for different diseases.

These findings can offer lucrative opportunities for the global protein assay market.

Recent Developments

  • A medical life science company, PerkinElmer, Inc. launched two assay kits named homogenous time-resolved fluorescence (HTRF) and AlphalLISA in April 2022. These kits are meant for the timely detection and quantification of Chinese hamster ovary (CHO) host cell protein (HCP) impurities.
  • A proteomic platform, providing biological understanding for research and development to the pharmaceutical as well as diagnostic firms was launched by a leading proteomics company, Biognosys in March 2022.
  • Eli Lilly and Company acquired Protomer Technologies in July 2021.
  • GeoMx DSP Protein Assays was launched by NanoString Technologies, Inc., a biotech company in November 2020.

Market Segmentation

Global protein assay market is segmented based on type, product, technology, application, end-user, and region. Based on type, the market is categorized into dye-binding assays, test strip-based assays, copper-ion-based assays, and others. Based on product, the market is divided into reagents, kits, and instruments & accessories. Based on technology, the market is fragmented into calorimetric protein assays, fluorescence-based protein assays, and absorbance-based protein assays. Based on application, the market can be divided into drug discovery and development, disease diagnosis, and others. Based on end users, the market can be further segmented into pharmaceutical and biotechnology companies, clinical laboratories, hospitals, academic research institutes, and others.

Company Profiles

The major players in the global protein assays market are Becton Dickinson and Co, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc, Merck KGaA, Abcam PLC, PerkinElmer Inc., QIAGEN NV, Lonza Group AG, Bio-Techne Corp, Illumina Inc, among others.

Report Scope:

In this report, global protein assays market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Protein Assays Market, By Type:

  • Dye Binding Assays
  • Test Strip-Based Assays
  • Copper-Ion-Based Assays
  • Others

Protein Assays Market, By Product:

  • Reagents
  • Kits
  • Instruments and Accessories

Protein Assays Market, By Technology:

  • Colorimetric Protein Assays
  • Fluorescence-Based Protein Assays
  • Absorbance-Based Protein Assays

Protein Assays Market, By Application:

  • Drug Discovery and Development
  • Disease Diagnosis
  • Others

Protein Assays Market, By End User:

  • Pharmaceutical and Biotechnology Companies
  • Clinical Laboratories
  • Hospitals
  • Academic Research Institutes
  • Others

Protein Assays Market, By Region:

  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • North America
    • United States
    • Mexico
    • Canada
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global protein assays market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Clinical Trial Analysis

  • 5.1. Ongoing Clinical Trials
  • 5.2. Completed Clinical Trials
  • 5.3. Terminated Clinical Trials
  • 5.4. Breakdown of Pipeline, By Development Phase
  • 5.5. Breakdown of Pipeline, By Status
  • 5.6. Breakdown of Pipeline, By Study Application
  • 5.7. Breakdown of Pipeline, By Region
  • 5.8. Clinical Trials Heat Map

6. Patents Analysis

7. Global Protein Assays Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type (Dye Binding Assays, Test Strip-Based Assays, Copper-Ion-Based Assays, Others)
    • 7.2.2. By Product (Reagents, Kits, Instruments and Accessories)
    • 7.2.3. By Technology (Colorimetric Protein Assays, Fluorescence-Based Protein Assays, Absorbance-Based Protein Assays)
    • 7.2.4. By Application (Drug Discovery and Development, Disease Diagnosis, Others)
    • 7.2.5. By End User (Pharmaceutical and Biotechnology Companies, Clinical Laboratories, Hospitals, Academic Research Institutes, Others)
    • 7.2.6. By Region
    • 7.2.7. By Company (2022)
  • 7.3. Product Market Map
    • 7.3.1. By Type
    • 7.3.2. By Product
    • 7.3.3. By Technology
    • 7.3.4. By Application
    • 7.3.5. By End User
    • 7.3.6. By Region

8. Asia-Pacific Protein Assays Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type (Dye Binding Assays, Test Strip-Based Assays, Copper-Ion-Based Assays, Others)
    • 8.2.2. By Product (Reagents, Kits, Instruments and Accessories)
    • 8.2.3. By Technology (Colorimetric Protein Assays, Fluorescence-Based Protein Assays, Absorbance-Based Protein Assays)
    • 8.2.4. By Application (Drug Discovery and Development, Disease Diagnosis, Others)
    • 8.2.5. By End User (Pharmaceutical and Biotechnology Companies, Clinical Laboratories, Hospitals, Academic Research Institutes, Others)
    • 8.2.6. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Protein Assays Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By Technology
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. India Protein Assays Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By Technology
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. Japan Protein Assays Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By Technology
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. South Korea Protein Assays Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Product
        • 8.3.4.2.3. By Technology
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Australia Protein Assays Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Product
        • 8.3.5.2.3. By Technology
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. Europe Protein Assays Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type (Dye Binding Assays, Test Strip-Based Assays, Copper-Ion-Based Assays, Others)
    • 9.2.2. By Product (Reagents, Kits, Instruments and Accessories)
    • 9.2.3. By Technology (Colorimetric Protein Assays, Fluorescence-Based Protein Assays, Absorbance-Based Protein Assays)
    • 9.2.4. By Application (Drug Discovery and Development, Disease Diagnosis, Others)
    • 9.2.5. By End User (Pharmaceutical and Biotechnology Companies, Clinical Laboratories, Hospitals, Academic Research Institutes, Others)
    • 9.2.6. By Country
  • 9.3. Europe: Country Analysis
    • 9.3.1. France Protein Assays Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By Technology
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. Germany Protein Assays Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By Technology
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. United Kingdom Protein Assays Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By Technology
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User
    • 9.3.4. Italy Protein Assays Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Product
        • 9.3.4.2.3. By Technology
        • 9.3.4.2.4. By Application
        • 9.3.4.2.5. By End User
    • 9.3.5. Spain Protein Assays Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Type
        • 9.3.5.2.2. By Product
        • 9.3.5.2.3. By Technology
        • 9.3.5.2.4. By Application
        • 9.3.5.2.5. By End User

10. North America Protein Assays Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type (Dye Binding Assays, Test Strip-Based Assays, Copper-Ion-Based Assays, Others)
    • 10.2.2. By Product (Reagents, Kits, Instruments and Accessories)
    • 10.2.3. By Technology (Colorimetric Protein Assays, Fluorescence-Based Protein Assays, Absorbance-Based Protein Assays)
    • 10.2.4. By Application (Drug Discovery and Development, Disease Diagnosis, Others)
    • 10.2.5. By End User (Pharmaceutical and Biotechnology Companies, Clinical Laboratories, Hospitals, Academic Research Institutes, Others)
    • 10.2.6. By Country
  • 10.3. North America: Country Analysis
    • 10.3.1. United States Protein Assays Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By Technology
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Mexico Protein Assays Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By Technology
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User
    • 10.3.3. Canada Protein Assays Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By Technology
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User

11. South America Protein Assays Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type (Dye Binding Assays, Test Strip-Based Assays, Copper-Ion-Based Assays, Others)
    • 11.2.2. By Product (Reagents, Kits, Instruments and Accessories)
    • 11.2.3. By Technology (Colorimetric Protein Assays, Fluorescence-Based Protein Assays, Absorbance-Based Protein Assays)
    • 11.2.4. By Application (Drug Discovery and Development, Disease Diagnosis, Others)
    • 11.2.5. By End User (Pharmaceutical and Biotechnology Companies, Clinical Laboratories, Hospitals, Academic Research Institutes, Others)
    • 11.2.6. By Country
  • 11.3. South America: Country Analysis
    • 11.3.1. Brazil Protein Assays Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By Product
        • 11.3.1.2.3. By Technology
        • 11.3.1.2.4. By Application
        • 11.3.1.2.5. By End User
    • 11.3.2. Argentina Protein Assays Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By Product
        • 11.3.2.2.3. By Technology
        • 11.3.2.2.4. By Application
        • 11.3.2.2.5. By End User
    • 11.3.3. Colombia Protein Assays Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By Product
        • 11.3.3.2.3. By Technology
        • 11.3.3.2.4. By Application
        • 11.3.3.2.5. By End User

12. Middle East and Africa Protein Assays Market Outlook

  • 12.1. Market Size & Forecast
    • 12.1.1. By Value
  • 12.2. Market Share & Forecast
    • 12.2.1. By Type (Dye Binding Assays, Test Strip-Based Assays, Copper-Ion-Based Assays, Others)
    • 12.2.2. By Product (Reagents, Kits, Instruments and Accessories)
    • 12.2.3. By Technology (Colorimetric Protein Assays, Fluorescence-Based Protein Assays, Absorbance-Based Protein Assays)
    • 12.2.4. By Application (Drug Discovery and Development, Disease Diagnosis, Others)
    • 12.2.5. By End User (Pharmaceutical and Biotechnology Companies, Clinical Laboratories, Hospitals, Academic Research Institutes, Others)
    • 12.2.6. By Country
  • 12.3. MEA: Country Analysis
    • 12.3.1. South Africa Protein Assays Market Outlook
      • 12.3.1.1. Market Size & Forecast
        • 12.3.1.1.1. By Value
      • 12.3.1.2. Market Share & Forecast
        • 12.3.1.2.1. By Type
        • 12.3.1.2.2. By Product
        • 12.3.1.2.3. By Technology
        • 12.3.1.2.4. By Application
        • 12.3.1.2.5. By End User
    • 12.3.2. Saudi Arabia Protein Assays Market Outlook
      • 12.3.2.1. Market Size & Forecast
        • 12.3.2.1.1. By Value
      • 12.3.2.2. Market Share & Forecast
        • 12.3.2.2.1. By Type
        • 12.3.2.2.2. By Product
        • 12.3.2.2.3. By Technology
        • 12.3.2.2.4. By Application
        • 12.3.2.2.5. By End User
    • 12.3.3. UAE Protein Assays Market Outlook
      • 12.3.3.1. Market Size & Forecast
        • 12.3.3.1.1. By Value
      • 12.3.3.2. Market Share & Forecast
        • 12.3.3.2.1. By Type
        • 12.3.3.2.2. By Product
        • 12.3.3.2.3. By Technology
        • 12.3.3.2.4. By Application
        • 12.3.3.2.5. By End User

13. Market Dynamics

  • 13.1. Drivers
    • 13.1.1. Increasing Research in Proteomics
    • 13.1.2. Increasing Government Fundings
    • 13.1.3. Cancer Detection with Protein Assays
  • 13.2. Challenges
    • 13.2.1. Stringent Regulatory Framework
    • 13.2.2. Dearth of Skilled Professionals
    • 13.2.3. Issue Regarding the Development of Protein Assays

14. Market Trends & Developments

  • 14.1. Miniaturization of Assay Equipment
  • 14.2. Advancements in Biomarker
  • 14.3. Increasing Launches of New Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Company Snapshot
  • 15.3. Products & Services
  • 15.4. Financials (As Reported)
  • 15.5. Recent Developments
  • 15.6. SWOT Analysis
    • 15.6.1. Becton Dickinson and Co
    • 15.6.2. Thermo Fisher Scientific Inc.
    • 15.6.3. Bio-Rad Laboratories Inc
    • 15.6.4. Merck KGaA
    • 15.6.5. Abcam PLC
    • 15.6.6. PerkinElmer Inc.
    • 15.6.7. QIAGEN NV
    • 15.6.8. Lonza Group AG
    • 15.6.9. Bio-Techne Corp
    • 15.6.10. Illumina Inc

16. Strategic Recommendations